Request Demo
Recent blog posts
Latest Hotspot
8 min read
IKBKB 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IKBKB, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
RELA 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for RELA, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
NFKB1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for NFKB1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
STAT5B 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for STAT5B, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
STAT5A 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for STAT5A, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
STAT3 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for STAT3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
TYK2 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for TYK2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
JAK3 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for JAK3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
JAK2 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for JAK2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
JAK1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for JAK1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IL6R 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IL6R, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IL6 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IL6, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.